Clinical Trial Update: The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg [Phase 4]

View source ↗

Summary

This document provides a Phase 4 clinical trial update on optimizing Peginterferon alpha treatment in chronic hepatitis B patients with low levels of HBsAg.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alpha (peginterferon alfa)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN